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In this paper we examine the link between retrospectively reported measures of childhood health and
the prevalence of various major and minor diseases at older ages. Our analysis is based on comparable
retrospective questionnaires placed in the Health and Retirement Study and the English Longitudinal
Study of Ageing – nationally representative surveys of the age 50 plus population in America and
England respectively. We show that the origins of poorer adult health among older Americans compared
to the English trace right back into the childhood years – the American middle and old-age population
report higher rates of specific childhood health conditions than their English counterparts. The transmission
into poor health in mid life and older ages of these higher rates of childhood illnesses also appears
to be higher in America compared to England. Both factors contribute to higher rates of adult illness
in the United States compared to England although even in combination they do not explain the full
extent of the country difference in late-life health outcomes.
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  International comparisons of health have risen in importance as a method of gaining 
insight into social and economic determinants of health status. Partly, this is due to the recent 
discovery and documentation of large unexplained differences in morbidity health outcomes that 
suggest that Americans are much sicker than their Western European counterparts (Banks, 
Marmot, Oldfield, and Smith, 2006; Avendano et al, 2009). In a set of recent papers, we 
compared disease prevalence among middle age adults 55-64 and at older ages in England and in 
the US (Banks Marmot, Oldfield and Smith (2006, 2009); Banks, Muriel and Smith (2010); 
Banks, Berkman, and Smith, 2011). Based on self-reported prevalence of seven important 
illnesses (diabetes, heart attack, hypertension, heart disease, cancer, diseases of the lung, and 
stroke), Americans were much less healthy than their English counterparts. These differences 
were large at all points of the SES distribution.  
Biological markers of disease showed similar health disparities between Americans and 
the English, suggesting that these large health differences were not a result of differential 
reporting of illness. We also found that these health differences existed with equal force among 
both men and women (Banks, Marmot, Oldfield, and Smith. 2009). Since we purposely excluded 
minorities (African-Americans and Latinos in American and non-Whites in England), these 
differences were not solely due to health issues in the minority or immigrant population. 
Moreover, these disparities in prevalence of chronic illness were also not the consequence of 
differences between the two countries in conventional risk factors such as smoking, obesity, and 
drinking – estimates of health disparities were essentially unchanged when we controlled for 
different levels of these risk factors in America and in England. Models of diabetes prevalence 
which controlled for both BMI and waist circumference displayed much reduced country   3
differences (Banks, Kumari, Smith and Zaninotto, 2011). However, the extent to which this can 
be interpreted as an ‘explanation’ of cross-country diabetes differences is somewhat limited if 
one views raised waist circumference for a given BMI as part of the fundamental etiology of 
diabetes. We still have to be able to explain why- for given levels of obesity- Americans have 
larger waists than the English.  All in all, therefore, it remains the case that much of the US-
English difference in later life adult health remains unexplained.  
In this paper, we investigate another hypothesis to help us understand underlying reasons 
for the large American health disadvantage. This hypothesis is that differential prevalence and 
differential impacts of early life conditions, and particularly childhood health, between England 
and the US may have lead to differences in subsequent later-life health outcomes. Considerable 
evidence has emerged that variation in health outcomes at middle and older ages may be traced 
in part to health and other conditions during childhood (Barker, 1997, Case et al, 2002, Case et 
al, 2005, Currie and Stabile, 2003, Smith, 2009, Smith and Smith, 2010). In this paper, we will 
test whether such variation accounts for important parts of country differences in adult health. 
  This remainder of this paper is divided into four sections. The next section describes the 
data that we will use in this analysis while the section that follows compares prevalence of 
childhood illnesses for birth cohorts in the two countries. Section 4 summarizes the main results 
obtained from analytical models relating these childhood illnesses to measures of adult health. 
The purpose of this analysis is to assess how much of the large differences in illness at middle 
and older ages in America compared to England can be explained by any differences that 
prevailed  when these people were children and adolescents. The final section of the paper 
highlights our main conclusions. 
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2. Childhood Health Data in the HRS and ELSA 
 
  This research uses data from two surveys — the English Longitudinal Survey of Aging 
(ELSA) and the US Health and Retirement Survey (HRS). Both surveys collect longitudinal data 
on health, disability, economic circumstances, work, and well-being, from a representative 
sample of the English and American populations aged 50 and older. Both ELSA and HRS are 
widely viewed as strong in the measurement of socioeconomic variables (education, 
employment, income, wealth) and health (self-reported subjective general health status, 
prevalence and incidence of physical and mental disease during the post age 50 adult years 
(hypertension, heart disease, diabetes, stroke, chronic lung diseases, asthma, arthritis and cancer, 
and emotional and mental illness including depression), disability and functioning status, and 
several salient health behaviors (smoking, alcohol consumption, and physical activity). HRS and 
ELSA have both been widely used in stand alone studies as well as comparative studies of adult 
health. 
One limitation of ELSA and HRS, along with the various other new international aging 
data sets, is that data collection only begins at age 50 (and even later for those cohorts who were 
older at the time of the initial baseline interview). Fortunately, this limitation was recognized, 
and many of these data sets subsequently fielded questionnaires or questionnaire modules that 
aimed to fill in, through retrospective recall, the more salient episodes in respondents’ pre-
baseline life histories. Childhood events including childhood health were an important part of 
these life history interviews.  
Both HRS and ELSA included very similar retrospectively reported childhood health 
histories. ELSA fielded their childhood health history between its wave 3 and wave 4 core 
interviews between February and August 2007.  ELSA used a stand alone ‘life-history’ CAPI   5
personal interview covering a variety of childhood circumstances and events as well as the pre-
baseline adult years. All ELSA respondents were eligible, and there was an eighty percent 
response rate (N= 7,855). For the purposes of our analysis, the data from the life history 
questionnaire was combined with the data from the third wave the main interview which was 
fielded between June 2006 and March 2007.  The HRS childhood health history was initially 
placed into an internet survey in 2007 for those respondents who had internet access and who 
agreed to be interviewed in that mode (N=3,641). The remainder of HRS respondents  
(N=12,337) received the same childhood health history as part of the 2008 core interview.
1  
  In addition to a subjective question rating their childhood health before age 16 on the 
standard five-point scale from excellent to poor, respondents in both surveys were asked about 
the occurrence of a set of common childhood illnesses. If the condition did exist, they were asked 
the age of first onset. The list of childhood illnesses that were asked was very similar in the two 
surveys but not identical-  some diseases were asked in one survey but not the other.
2 Thus, we 
confine our analysis in this paper only to childhood illnesses and conditions that were asked in 
both surveys. Even within these set of childhood conditions, there are differences in wording or 
inclusion that must be taken into account. The following childhood diseases have basically the 
same wording in both surveys—asthma, diabetes, heart trouble, chronic ear problems, severe 
headaches or migraines, and epilepsy or seizures. For the common childhood infectious diseases, 
HRS respondents were asked about mumps, measles, and chicken pox separately while ELSA 
                                                 
1 See Smith, 2009a for details. 
2 For example, the following childhood conditions and diseases were asked in ELSA but not in HRS- broken bones 
and fractures; appendicitis; leukemia or lymphoma; cancer or malignant tumor. The following conditions were asked 
in HRS but not in ELSA- difficulty seeing even with glasses or prescription lenses; a speech impairment; stomach 
problems; high blood pressure; a blow to the head, head injury or trauma severe enough to cause loss of 
consciousness or memory loss for a period of time.   6
respondents were asked a single question about all infectious disease with the question wording 
mentioning these three diseases but also including polio and TB.  
The biggest difference between the two surveys involves allergies and respiratory 
problems. In HRS, respondents were asked about respiratory disorders which included 
bronchitis, wheezing, hay fever, shortness of breath, and sinus infections and were separately 
asked about any allergic conditions. ELSA respondents were asked about allergies including hay 
fever and then separately about respiratory problems. Thus, hay fever shows up in a different 
category in the two surveys. The other difference of possible significance concerns the category 
of emotional and psychological problems which included two questions about depression and 
other emotional problems in HRS and one question about emotional, nervous, or psychiatric 
problems in ELSA. 
In addition to any impact of these wording differences, the form in which the questions 
were asked also differed between the two surveys. HRS respondents were asked separate 
questions about each condition while ELSA respondents were shown a ‘show card’ which 
contained a list of conditions and then asked to identify any that they may have had before age 
16. The show card format could lead to lower reported prevalence if respondents that had 
multiple conditions only identify a subset from show cards, whilst they would have answered in 
the affirmative to each of the questions individually had they been asked.  
 
3. Comparing Childhood Health in England and the USA 
Our first descriptive analysis compares prevalences of childhood conditions that are more 
or less comparably defined in England and the United States using these two surveys. In addition 
to presenting overall prevalence in the two samples, we also stratified the data by four broadly   7
defined birth cohorts—those born pre 1930, those born between 1930 and 1939, those born 
between 1940 and 1949, and those born in 1950 or after. Given the age selection of HRS and 
ELSA respondents and the fact that both samples were refreshed with younger cohorts prior to 
the retrospective data collection (in 2006 for ELSA and 2004 for HRS), the youngest cohort of 
our sample contains only those born between 1950 and 1956. 
Such age stratification may reveal the nature of any secular trends in the prevalence of 
childhood diseases in the two countries. Given the reliance on recall for this data, however, 
considerable caution in interpreting any age patterns is advisable. One problem involves 
mortality selection if those with healthier childhoods live longer as they undoubtedly do. This is 
a selection effect that should become stronger at older ages.  
Since these prevalence measures are based on recall, a second problem is that memory 
biases may be playing a role in these trends as well and these may also be stronger at older ages. 
It is well established that memory typically declines with time from the event (Sudman and 
Bradburn, 1974). Salient events may suffer less from this type of memory decay and memory of 
childhood happenings appear to be superior than for other times of life. Smith (2009a) shows that 
data from these recall histories on childhood health show similar age-cohort patterns to those 
collected from contemporaneous sources for example.  
The third and final problem is the difficulty in separating cohort or time trends in true 
prevalence and incidence from improved detection or changing diagnostic thresholds. For most 
childhood diseases, there is very likely improved diagnosis and detection of childhood diseases 
over time, and for some diseases, including mental illness, there may be some effect of a 
lowering of the threshold for diagnosis.   8
Table 1. Childhood Disease Prevalence in the HRS and ELSA (%) 
  Heart Disease  Emotional  Diabetes  Epilepsy  Ear 
  ELSA  HRS  ELSA  HRS  ELSA  HRS  ELSA  HRS  ELSA  HRS 
Pre 1930  0.49  2.06  1.33  2.63  0.00  0.11  0.24  0.34  5.06  8.56 
1930-1939  0.64  1.87  1.55  2.98  0.05  0.11  0.54  0.47  7.62  8.99 
1940-1949  0.93  2.32  2.38  3.75  0.00  0.08  0.59  0.67  7.28  9.39 
1950-1956  0.70  1.74  1.75  4.52  0.06  0.47  0.91  0.89  6.42  10.06 
                     
All  0.73  2.05  1.85  3.53  0.02  0.18  0.59  0.61  6.80  9.29 
 
 
  Migraines  Asthma  Respiratory  Allergies 
  ELSA  HRS  ELSA  HRS  ELSA  HRS  ELSA  HRS 
Pre 1930  2.90  4.47  2.48  2.33  7.61  7.12  3.29  4.50 
1930-1939  4.14  4.41  2.80  3.10  8.61  10.77  4.36  6.54 
1940-1949  5.64  5.03  3.38  4.54  9.65  12.41  6.19  9.76 
1950-1956  6.30  6.28  3.97  4.02  8.32  13.33  8.76  11.49 
                 
All  4.94  5.04  3.21  3.69  8.75  11.27  5.80  8.42 
 
 
With these caveats in mind, Table 1 presents the patterns revealed in the data on the 
prevalence of early life health conditions in England and the United States. The first pattern of 
note is that across all ages in all nine childhood diseases reported prevalence is actually higher in 
the United States than in England. In some cases, the prevalence rates are rather close (epilepsy, 
migraines, and asthma), but in most cases the rates in the United States are much higher 
especially if we use relative risk as the metric for comparison. For example, there is a 45% 
higher risk of childhood allergies in the United States and a 29% higher risk of respiratory 
problems in the US compared to England. Since England includes hay fever in allergies and the 
US in respiratory, the relative risk difference between the two countries is even higher for 
allergies. Similarly, even though overall prevalence is low in both countries, relative risk of 
childhood heart disease and diabetes is much higher in the United States. Supporting evidence 
for an American excess of childhood disease compared to the English comes from Martinson et al. 
(2011) who demonstrate using biomarker data from NHANES and the Health Survey for England that in   9
more contempory times there is also an American excess of childhood disease. It is important to note that 
their comparisons do not rely on recall. 
The second salient pattern in these data is country differences in across cohort trends. 
While for most childhood diseases in both countries secular trends indicate growing prevalence 
over time, these secular trends appear to be much sharper in the United States than in England. 
For example, take respiratory diseases as the first example—childhood prevalence is almost 
twice as high in the youngest birth cohorts compared to the oldest birth cohorts in Table 1. The 
comparable figure for England is 9% higher.  
We have discussed three potential difficulties in interpreting the cross-cohort trends in 
Table 1, namely mortality selection, imperfect recall and secular trends in diagnosis. In principal, 
each of these effects could also be operating differentially in England and the US, and hence 
affecting our cross-country comparisons as well. Of the three, the one that is most amenable to 
investigation is mortality selection, and particularly the concern that cohort trends in mortality 
selection may be rather different in the two countries.  
What would be most worrying would be higher rates of mortality prior to older ages in 
England. This might lead one to suppose that those who had the specific childhood conditions 
identified in this table would be more likely to have died in England than in the US, hence 
leading us to measure lower prevalence in England when we interview survivors of these cohorts 
many years later. In previous research, we have already documented lower mortality rates in 
England between ages 50 and 65 (Banks, Smith and Muriel, 2010) so to further our evidence on 
this issue we analyzed the Human Mortality Base data
3 on survival to various ages for the two 
countries for all cohorts born between 1934 and 1958 (data on earlier cohorts are not available 
for the US).  The analysis (presented in Figure A1 in the Appendix) demonstrates that English 
                                                 
3 http://www.mortality.org/   10
cohorts were in fact more likely to survive to age 50 than their US counterparts. If childhood 
disease is predictive of mortality prior to age 50, we may if anything be understating the true 
prevalence differences between the two countries at the time these cohorts were young.  
Interestingly, cohort trends in these survival probabilities are somewhat different across 
countries. For cohorts born from 1948 onwards the differences between countries in the 
likelihood of living to age 50 becomes rather more substantial than for the earlier cohorts. Once 
again this cohort-specific country divergence may be worrying for our analysis. But further 
investigation of this feature indicates that it is due to a sharp increase in the probability of living 
to age 1 in England after the Second World War
4 for these later cohorts so that their survival 
rates were comparable to similar cohorts in the US whilst their predecessors had rather lower 
survival probabilities. When we look at cohort trends in survival to age 50 conditional on 
survival to age 1, the pattern of cohort trends in the two countries is much more comparable 
with, in fact, an even greater advantage in favor of the English. Given that much of the diagnosis 
and onset of our childhood conditions will occur after age 1 it is this last evidence that we think 
is most relevant for our purposes here. 
Turning back to the ELSA and HRS childhood data that form the core of our analysis, 
Table 2 compares later-life health outcomes in England and the United States, with the outcomes 
measured at or near to the time the retrospective data were collected (i.e. 2007 in England and 
2007/8 in the US). We divide health outcomes into three groups—illnesses that we label major, 
those labeled minor, and those labeled ‘Barker’. Major illness includes cancer, lung disease, 
stroke, angina, heart attack, and heart failure.  Minor illness includes hypertension, diabetes, and 
arthritis. ‘Barker’ illnesses include those related to heart disease and diabetes (angina, heart 
                                                 
4 One hypothesis is that this improvement in infant mortality in England in this period was due to better nutrition 
(Deaton 1976).    11
attach, heart failure, hypertension, and diabetes)- the diseases that are at the core of the Barker 
hypothesis linking early life and particularly in-utero factors to later life health. For both 
countries, prevalence rates are stratified by age and gender in Table 2. 
Table 2. Patterns of Types of Adult Illness in England and the United States 
(a) Major Adult Illness 
  Male  Female  Total 
Age   ELSA  HRS  ELSA  HRS  ELSA  HRS 
50-54  0.09  0.18  0.10  0.20  0.10  0.19 
55-59  0.15  0.25  0.12   0.25  0.13  0.25 
60-64  0.25  0.34  0.24   0.34  0.25  0.34 
65-69  0.30  0.44  0.28  0.37  0.29  0.40 
70-74  0.38  0.55  0.29  0.42  0.33  0.48 
75-79  0.49  0.64  0.36  0.50  0.42  0.56 
80-84  0.48  0.70  0.37   0.55  0.42  0.61 
85+  0.45  0.68  0.43  0.58  0.43  0.61 
Total  0.27  0.40  0.24  0.37  0.26  0.38 
 
(b) Minor Adult Illness 
  Male  Female  Total 
Age  ELSA  HRS  ELSA  HRS  ELSA  HRS 
 50-54  0.41  0.53  0.38  0.60  0.39  0.56 
55-59   0.55  0.65  0.56  0.66  0.56  0.65 
 60-64  0.63  0.70  0.64  0.78  0.63  0.74 
 65-69  0.64  0.80  0.73  0.83  0.69  0.82 
 70-74  0.71  0.82  0.78  0.86  0.75  0.84 
 75-79  0.73  0.87  0.79  0.88  0.76  0.88 
 80-84  0.74  0.85  0.85  0.91  0.81  0.88 
  85+  0.74  0.85  0.82  0.90  0.79  0.89 
 Total  0.61  0.72  0.66  0.78  0.64  0.75 
 
(c) Barker Illness 
  Male  Female  Total 
Age  ELSA  HRS  ELSA  HRS  ELSA  HRS 
 50-54  0.33  0.43  0.25  0.42  0.29  0.43 
 55-59  0.45  0.53  0.38  0.45  0.42  0.49 
 60-64  0.51  0.59  0.43  0.55  0.47  0.57 
 65-69  0.55  0.70  0.52  0.64  0.54  0.67 
 70-74  0.61  0.71  0.61  0.68  0.61  0.69 
 75-79  0.69  0.77  0.66  0.73  0.67  0.74 
 80-84  0.67  0.78  0.69  0.78  0.68  0.78 
  85+  0.67  0.77  0.72  0.77  0.70  0.77 
 Total  0.52  0.62  0.49  0.59  0.51  0.60 
   12
There are several salient patterns revealed in Table 2. Not surprisingly for all three 
disease categories, disease prevalence rises rapidly with age in both countries, with ages in the 
fifties and sixties witnessing the most rapid rate of increase. Most importantly, across all three 
categories of illness used in this Table, Americans have much higher rates of disease than the 
English do. This pattern of excess illness in America compared to England when defined using 
these aggregated disease groupings appears to be true for men and women and accords with the 
various findings on the more specific conditions and diseases that we have documented in our 
other research (Banks et al, 2006, Banks et al, 2010). 
 
4. Analytical Models Comparing Effects of Childhood Health on Adult Health in England 
and the USA 
 
Table 3 presents our baseline OLS models that attempt to isolate the salient country level 
differences in adult disease prevalence. These models contain only a quadratic in age 
(normalized so that age 50 is zero and defined for expositional convenience as (age-50)/10)), a 
gender dummy (male = 1), a country dummy (US =1) and interactions of the US indicator 
variable with the age quadratic and gender. Not surprisingly given the patterns revealed in Table 
2, we find that all three disease groups increase with age at a decreasing rate
5, there is a small but  
statistically significant male disease excess for major and Barker disease categories and a small 
(but again statistically significant) female excess for minor diseases in England. In terms of our 
main interest in country differences, we find a statistically significant common excess of disease 
in the United States. On average, and for the base case individuals (50 year old females), disease 
excess in the US over England is 7.2 percentage points, for major diseases, 14.5 percentage 
points for minor diseases, and 11.1 percentage points for Barker diseases. There is no strong 
                                                 
5 As always, these age patterns could partially reflect cohort effects as well.   13
evidence that this American disease excess differs across age and gender since the US 
interactions with these variables are not generally statistically significant. 
Table 3. Modeling Country Differences in Adult Health Outcomes—Baseline Model 
 
  (major)  (minor)  (major or minor)  (Barker) 
age  0.177**  0.259**  0.274**  0.224** 
age2  -0.018**  -0.039**  -0.042**  -0.028** 
male  0.037**  -0.044**  -0.032**  0.042** 
US  0.072**  0.145**  0.159**  0.111** 
Age*US  0.030  -0.023  -0.045*   0.001 
Age2*US  -0.002  0.001  0.005  -0.003 
Male*US   0.025  0.002  0.011  -0.001 
constant  0.027  0.390**  0.423**  0.233** 
 
N  19,583  19,583  19,583  19,583 
  Note to table: * indicates p<0.05; ** indicates p<0.01 
 
In the Tables that follow, we expand the models in Table 3 with additional groups of 
covariates with an eye toward examining the marginal impact of these additions on the country 
level main effect differences in adult health status. The added covariates in Table 4 include our 
few available common measures of childhood circumstances, parental background and SES. 
These measures are (a) whether the mother or father of the respondent was dead at the time of 
the collection of the retrospective data, and if so their age of death which could be seen as 
measures of shared familial environment during the childhood years and/or genetic factors; (b) 
whether your SES was low during the childhood years based on fathers occupation when you 
were sixteen years old ; (c) adult height measured in centimeters (normalized to mean height – 
65 inches), an often used summary statistic to capture elements of the Barker hypothesis related 
to childhood nutrition. Once again, all variables in these models are interacted with a country 
dummy (US=1). These new variables in (a) and (c) could equally well be thought of as 
alternative indicators of childhood health. Parents and children shared genes forever and   14
environment for at least decades so that parental deaths and/or date of death may pick up 
elements of health transmitted from parents to their children. Even more so, adult height is often 
used as a summary statistic for childhood health, or at least the nutritional components of 
childhood health and as a marker for Barker related diseases.  
Table 4. Modeling Country Differences in Adult Health Outcomes—Adding Childhood SES 
Controls 
         (major)        (minor)        (major or  minor)  (Barker) 
   
age  0.178**  0.245**  0.259**   0.200** 
age  -0.019**  -0.038**  -0.040**  -0.026** 
male  0.047**  -0.022  -0.021  0.090** 
mother died  0.120**  0.118**  0.107**  0.156** 
mother age died  -0.001**  -0.001**  -0.001*  -0.001** 
father died  0.078*  0.101**  0.123**  0.183** 
father age died  -0.001  -0.001**  -0.002**  -0.002** 
ses_low  0.014  0.040**  0.038**  0.037** 
height  -0.002  -0.004*  -0.002  -0.009** 
 
US  0.069*  0.120**  0.150**  0.098** 
Age*US  -0.002  -0.042  -0.074**  -0.011 
age2*US  0.004  0.005  0.010*  0.001 
male*US  0.024  -0.004  0.013  -0.023 
mom died*US  0.021  -0.045  -0.017  -0.007 
mom age died* US  0.000  0.001  0.000  0.000 
dad died*US  0.077  0.012  -0.012  0.018 
dad age died*US  -0.001  0.001  0.001*  0.000 
ses low*US  0.013  -0.020  -0.017  -0.004 
height*US  0.001  0.002  0.000  0.005 
constant  -0.019  0.359**  0.380**  0.166** 
 
N  19,583  19,583  19,583  19,583 
Note to table: * indicates p<0.05; ** indicates p<0.01; Base group is a 50-year old female with mother and 
father alive, average height and high childhood SES. 
 
 
Examining the effects of new variables included in these models, all forms of adult 
disease are higher if either the mother or father of the respondent was dead at the time of the 
HRS or ELSA survey interview—an effect that is larger the younger the age at which parent 
died. The effect of these variables is not generally statistically significantly different in the two   15
countries though. Through either shared family environment or genetics, having a parent die at a 
younger age may indicate greater shared familial proneness to illness. Particularly for minor and 
Barker diseases, adult levels of disease are higher among those who were a member of a low 
SES family during their childhood years. Finally, consistent with Barker’s hypothesis, taller 
adults are also healthier adults. This association is especially strong for the Barker category of 
disease.  
Once again and somewhat remarkably, very few of the interactions of variables with the 
US country indicator are statistically significant with the exception of the US main effect which 
still signals statistically significantly higher levels of disease in America compared to England on 
average. This US level effect is only slightly smaller in Table 4 compared to that obtained in the 
baseline models in Table 3 indicating that this set of childhood SES/parental health measures do 
not contribute very much to ‘explaining’ the country difference in adult health.  
Our first attempt to evaluate the contributory role of childhood health towards country 
level adult disease differences is contained in Table 5 which adds to the set of variables in 
models in Table 4 the summary childhood measure of subjective health status, i.e. whether the 
respondents reports that they had excellent or very good health as a child. The other covariates 
are not appreciably altered by this addition of childhood subjective health so we will confine our 
discussion to the subjective childhood health measures.  The estimated effect of being in 
excellent or very good health during one’s childhood years is to lower the probability of all 
forms of adult disease. This association also appears to be statistically significantly larger in the 
United States compared to England, but only for the major disease category.  
However, the estimated overall average adult health differences between America and 
England in Table 5 has remained essentially unchanged compared to those in Table 4 and in the   16
case of major illnesses has actually increased from 0.069 to 0.102. If childhood health problems 
raise the probability of adult health problems and if, as the data in Table 1 indicate, there are 
more such problems in America than in England, how is it possible that these problems fail to 
explain the between country health difference or even more perversely make them even larger? 
 
Table 5. Modeling Country Differences in Adult Health Outcomes—Adding Childhood 
Subjective Health 
  (major)  (minor)  (major or minor)  (Barker) 
  b  b  b  b 
age  0.174**  0.241**  0.255**  0.199** 
age2  -0.018**  -0.037**  -0.039**  -0.026** 
male  0.047**  -0.023  -0.021  0.090** 
mother died  0.117**  0.115**  0.103**  0.154** 
mother age died  -0.001**  -0.001*  -0.001*  -0.001** 
father died  0.075*  0.097**  0.119**  0.181** 
father age died  -0.001  -0.001**  -0.002**  -0.002** 
ses_low  0.013  0.039**  0.037**  0.036** 
height   -0.002  -0.004  -0.002  -0.009** 
exc health as child  -0.047**  -0.053**  -0.057**  -0.024* 
 
US  0.102**  0.121**  0.145**   0.117** 
Age*US  0.001  -0.040  -0.072**  -0.010 
age2*US  0.004  0.005  0.010*  0.000 
male*US  0.023  -0.005  0.012  -0.024 
mother died*US  0.018  -0.044  -0.016  -0.008 
mother age died*US  0.000  0.001  0.000  0.000 
father died*US  0.074  0.013  -0.011  0.017 
father age died*US  -0.001  0.001  0.001*  0.000 
ses_low*US  0.013  -0.019  -0.016  -0.004 
height*US  0.001  0.002  0.000  0.005 
ex health as child*US  -0.031*  0.006  0.014  -0.019 
constant  0.018  0.401**  0.426**  0.185** 
 
N  19,583  19,583  19,583  19,583 
Note to table: * indicates p<0.05; ** indicates p<0.01. Base group is a 50-year old female with mother and 
father alive, average height, high childhood SES and good/fair/poor self-reported childhood health. 
 
Table 6 provides the answer by displaying country differences in excellent or very good 
subjective childhood health as a child by birth cohort in both England and the USA. In spite of 
the fact that the data in Table 1 show that in almost all childhood diseases for all birth cohorts   17
that Americans were sicker as children than their English counterparts, Table 6 indicates that 
when asked to evaluate their childhood health on a subjective scale that Americans respond that 
their childhoods were healthier than the responses of the English would indicate about their own 
English childhood.  The problem with using the childhood subjective health scale is actually the  
same as the problem with using the adult variant of these scales- given the same objective level 
of health on subjective scales Americans will report themselves as healthier than the English 
(Banks et al, 2009; Kapteyn, Smith, and van Soest, 2007).  For example the fraction of ELSA 
respondents who report in excellent or very good childhood health is 0.68 while in HRS it is 
0.78- a ten point differential in favor of the Americans. Because of this, and since being in 
excellent of very good child as a child is associated with better adult health in both countries, this 
will make the unexplained country adult health difference even larger.  
 
Table 6.  Fraction in Excellent of Very Good Health during Childhood in the HRS and ELSA 
  Male  Female  Total 
  ELSA  HRS  ELSA  HRS  ELSA  HRS 
Pre 1930    0.62  0.70  0.64  0.70  0.63  0.70 
1930-1939  0.68  0.76  0.61  0.78  0.64  0.77 
1940-1949  0.68  0.79  0.68  0.82  0.68  0.88 
1950-1956  0.77  0.81  0.71  0.79  0.74  0.80 
             
All    0.69  0.77  0.66  0.78  0.68  0.78 
 
 
Putting aside for a moment this problem of country differences in subjective scales, the 
within country patterns revealed in Table 6 are also of interest. The within country gender 
differences in subjective childhood health is not large. However, there is a clear and very 
pronounced trend across cohort in both countries where subjective childhood health is reported 
to be better among the more recent cohorts. If we compare most recent cohorts in Table 6 to the   18
oldest cohorts, the increase in the fraction in excellent or very good health as a child is about ten 
percentage points in both England and America. Whilst it is possible that childhood health 
improved across these cohorts (contrary to the evidence on chronic diseases presented in Table 1 
above, and subject to the various caveats and especially to the role of improved diagnosis we 
identified in the discussion of that table) the magnitude of this increase seems rather implausible, 
particularly in the presence of health survivor effects which would tend to work across cohorts in 
the opposite direction. This points to another major puzzle in the reconciliation of secular trends 
in subjective and objective childhood health measures. 
Table 7 extends our modeling of adult health in Table 6 by adding the set of childhood 
disease indicators to the model as well as interactions of this set of childhood diseases with the 
US country indicator variable. Since the prevalence rates of some of these childhood diseases are 
low, we aggregated them into six groups. The six groups are ear problems, respiratory, allergies,   
asthma, rare diseases (childhood diabetes, epilepsy, emotional), and all others. Main effects and 
interactions with the US country indicator are included in the model. Because of the across 
country scale comparability issue mentioned above, the model estimated in Table 7 does not 
include the subjective childhood health variable. 
Once again, coefficients of other variables in the model are not significantly affected by 
adding childhood disease indicators. The diseases that appear to have most consistently 
statistically significant main effects are ear problems, respiratory diseases, and rare diseases. 
Especially for major illness, transmission into poorer adult health appears to be stronger in the 
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Table 7. Modeling Country Differences in Adult Health Outcomes—Adding Childhood 
Disease Indicators 
  (major)  (minor)  (major or minor)  (Barker) 
   
age  0.175**  0.244**  0.258**  0.201** 
age2  -0.018**  -0.037**  -0.039**  -0.026** 
male  0.052**  -0.019  -0.016  0.090** 
mother died  0.120**  0.115**  0.104**  0.153** 
mother age died  -0.001**  -0.001*  -0.001*  -0.001** 
father died  0.080*  0.101**  0.123**  0.182** 
father age died  -0.001  -0.002**  -0.002**  -0.002** 
ses_low  0.016  0.040**  0.039**  0.036** 
height   -0.002  -0.004*  -0.002  -0.009** 
ear problems  0.045*  0.011  0.017  -0.014 
respiratory  0.092**  0.044*  0.073**  0.017 
allergies  -0.022  -0.036  -0.036  -0.027 
asthma  0.039  0.006  0.003  0.015 
rare  0.027  0.058**  0.063**  0.027 
all other  -0.004  -0.000  -0.009  -0.018 
 
US  0.041  0.110**  0.142**  0.080* 
age*US  0.005  -0.041  -0.072**  -0.010 
age2*US  0.004  0.005  0.011*  0.001 
male*_US  0.027  -0.004  0.011*  -0.020 
mother died*US  0.019  -0.041  -0.013  -0.005 
mother age died*US  0.000  0.001  0.000  0.000 
father died*US  0.071  0.010  -0.014  0.017 
father age died*US  -0.001  0.001  0.001*  0.000 
ses_low*US  0.013  -0.019  -0.017  -0.003 
height*US  0.001  0.002  0.001  0.005 
ear problems*US  0.002  0.027  0.015  0.045 
respiratory*US  -0.030  -0.018  -0.042*  -0.008 
allergies*US  0.030  0.042  0.039  0.030 
asthma*US  0.055  -0.005  0.020  0.015 
rare*US  0.101**  -0.015  -0.022  0.035 
all other*US  0.024  0.021  0.030  0.023 
constant  -0.034  0.350**  0.370**  0.167** 
 
N  19,583  19,583  19,583  19,583 
Note to table: * indicates p<0.05; ** indicates p<0.01. Base group is a 50-year old female with mother and 
father alive, average height, high childhood SES, good/fair/poor self-reported childhood health and no 
specific childhood health conditions. 
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  Table 8 provides a summary of the estimated main effect American excess of disease 
from our models in Tables 3 to 7. If we compare the estimates from Table 7 with the age 
adjusted ‘raw’ country differences from Table 3, the combination of SES/parental health 
transmission variables and the childhood diseases does ‘explain’ a significant part of the country 
differences. For example for major diseases, the raw difference in Table 3 was 7.2 percentage 
points of excess disease in America. The adjusted difference in Table 4 is 4.1 percentage points 
(and not statistically significant) so that using this metric 43% of the American excess major 
disease is explained compared to the base case model 
Table 8 Summary Table of Estimated US excess adult illness 
Model  Major   Minor   Barker 
Baseline (Table 3)  0.072**  0.145**  0.111** 
+ childhood SES (Table 4)  0.069*  0.120**  0.098** 
+ Childhood subjective health (Table 5)  0.102**  0.121**  0.117** 
+ Childhood diseases (Table 7)  0.041  0.110**  0.080* 
 + Childhood diseases but without US 
interaction with disease (Table A.1) 
0.082*  0.113*  0.113** 
** statistically significant at one percent level. *   Statistically significant at five percent level 
 
The comparable numbers for minor diseases is a 14.5 percentage point ‘raw’ disease 
excess in America and an 11.1 percentage point adjusted excess so that 23% of the excess is 
explained. Finally, for the Barker diseases, the comparable numbers are 11.1 ‘raw’ and 8.0 
‘adjusted’ so that 28% of the American excess is explained. 
  As a final note, it is instructive to consider the degree to which this ‘explanation’ of the 
excess disease in the US arises from the inclusion in the model of the indicators of prevalence of 
the specific childhood illnesses themselves as opposed to the interactions of these prevalence   21
indicators with the US country dummy. To investigate this we ran a similar model to that 
presented in Table 7 but with the childhood health country interaction terms excluded (full 
estimates presented in Table A1 in the Appendix and estimates of the US intercept term 
presented in the final row of Table 8). On comparison of these results with those discussed 
above, it is apparent that the main contribution to the reduction in both the size and statistical 
significance of the US country effect arises from the inclusion of the interaction terms – whilst 
there is some role for the greater prevalence of childhood conditions in the US, it is the 
differential impacts of these childhood conditions on later-life health outcomes in the US that has 
the main effect on changing the coefficient on the US dummy variable. Whilst these interaction 
terms are, of course, just another form of 'country effect', this does suggest that investigation of 
the mechanisms by which early-life health is transmitted to late-life disease outcomes in the two 
countries would be a promising avenue for future research.  
  
6. Conclusions 
  Differences in prevalence of childhood diseases between England and the United States 
and a higher rate of transmission into poorer adult health in the United States do appear to 
contribute to higher rates of adult illness in the United States compared to England. Our results 
in this paper show that, based on comparable retrospective questionnaires placed in HRS and 
ELSA- nationally representative surveys of the age 50 plus population in America and England 
respectively, the origins of poorer adult health among older Americans compared to the English 
traces back right into the childhood years. The transmission rates of these higher rates of 
childhood illnesses into poor health in mid life and older ages also appears to be higher in 
America compared to England.   22
  Of course, every partial answer raises yet another question. In this case, conditions in 
America appear to make people of all ages sicker than the English. This conclusion highlights a 
caution that age specific answers to the question of why Americans are sicker may not serve as a 
useful guide to uncovering the more fundamental causes of this important question. Our research 
shows that the primary sources of the American excess in disease are not unique to mid 
adulthood or old age but are more common throughout the age distribution of the two 
populations. Finally, it is worth noting that we are dealing in this research with the onset of 
disease rather than the treatment of disease so that the medical system and availability of health 
insurance are not likely to be the primary actors in this puzzle. This is particularly true given our 
use of a non-Hispanic white sample so 95% of our American sample have access to health 
insurance.  
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APPENDIX 
Table A.1  Modeling Country Differences in Adult Health Outcomes—Adding Childhood 
Disease Indicators without Interaction Terms 
  (major)  (minor)  (major or minor)  (Barker) 
  b  b  b  b 
age  0.175**  0.240**  0.255**  0.199** 
age2  -0.018**  -0.036**  -0.039**  -0.026** 
male  0.055**  -0.019  -0.017  0.093** 
mother died  0.117**  0.114**  0.103**  0.153** 
mother age died  -0.001**  -0.001*  -0.001*  -0.001** 
father died  0.077*  0.099**  0.121**  0.182** 
father age died  -0.001  -0.001**  -0.002**  -0.002** 
ses_low  0.016  0.040**  0.038**  0.037** 
height   -0.002  -0.004*  -0.002  -0.009** 
exc health as child  -0.023*  -0.045**  -0.047**  -0.018 
ear problems  0.044*  0.025*  0.023*  0.015 
respiratory  0.069**  0.026*  0.040**  0.009 
allergies  -0.003  -0.009  -0.012  -0.007 
asthma  0.064**  -0.008  0.005  0.018 
rare  0.090**  0.042**  0.042**  0.047** 
all other  0.007  0.007  0.005  -0.006 
US  0.082*  0.113*  0.136**  0.113** 
Age*US  0.003  -0.039  -0.070**  -0.010 
age2*US  0.004  0.005  0.010*  0.000 
male*US  0.023  -0.005  0.013  -0.024 
mother died*US  0.019  -0.044  -0.015  -0.007 
mother age died*US  0.000  0.001  0.000  0.000 
father died*US  0.071  0.010  -0.011  0.017 
father age died*US  -0.001  0.001  0.001*  0.000 
ses_low*US  0.012  -0.019  -0.016  -0.004 
height*US  0.001  0.002  0.000  0.005* 
ex health as child*US  -0.020  0.011  0.019  -0.015 
constant  -0.027  0.385**  0.407**  0.173** 
 
N  19,583  19,583  19,583  19,583 
 
   
 Figure A1: Survival probabilities in England and Wales compared to the United States 
by date of birth cohort 
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Figure 1(b) 
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Figure 1(c) 
Probability of surviving to age 50, conditional  
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Source: Authors’ calculations from Human Mortality Database 
 
 